Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 40, Issue 11-12, Pages 1270-1281
Publisher
Wiley
Online
2014-10-18
DOI
10.1111/apt.12992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials
- (2014) David J. Pinato et al. PLoS One
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review
- (2013) Yan Zhao et al. Asia-Pacific Journal of Clinical Oncology
- Inflammation as a validated prognostic determinant in carcinoma of unknown primary site
- (2013) Z Mohamed et al. BRITISH JOURNAL OF CANCER
- Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma
- (2013) Min Ju Kim et al. CYTOKINE
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
- (2013) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma
- (2013) Gao Heng-jun et al. LIVER INTERNATIONAL
- Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
- (2012) A Kinoshita et al. BRITISH JOURNAL OF CANCER
- A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
- (2012) D J Pinato et al. BRITISH JOURNAL OF CANCER
- High-Sensitivity C-Reactive Protein Levels and Cancer Mortality
- (2012) Y.-J. Ko et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
- (2012) Wolfgang Sieghart et al. HEPATOLOGY
- A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
- (2012) David J. Pinato et al. JOURNAL OF HEPATOLOGY
- Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
- (2012) David James Pinato et al. Journal of Thoracic Oncology
- Gene Signatures in the Management of Hepatocellular Carcinoma
- (2012) Yujin Hoshida et al. SEMINARS IN ONCOLOGY
- An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
- (2012) David J. Pinato et al. Translational Research
- Chemoembolization in Patients with Hepatocellular Carcinoma
- (2012) Riccardo Lencioni Liver Cancer
- Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
- (2011) G. Cabibbo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients
- (2011) Mitsuru Ishizuka et al. AMERICAN JOURNAL OF SURGERY
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
- (2011) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Treatment Strategy for Hepatocellular Carcinoma with Major Portal Vein or Inferior Vena Cava Invasion: A Single Institution Experience
- (2011) Hiroyuki Yoshidome et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer
- (2011) Wei Chua et al. SUPPORTIVE CARE IN CANCER
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
- (2010) S. C. H. Kao et al. CLINICAL CANCER RESEARCH
- Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?
- (2010) R. Lencioni et al. ONCOLOGIST
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Inflammation and Liver Cancer
- (2009) C. Berasain et al. Annals of the New York Academy of Sciences
- Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design
- (2009) Chiun Hsu et al. Contemporary Clinical Trials
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More